|
Eli Lilly cut its outlook for fourth-quarter revenue citing sluggish growth in the market for incretin, which increases insulin levels.
|
|
US Inflation Data to Remain Firm, Feeding Fears of Higher Rates BloombergJPMorgan's view on Wednesday's inflation reading and how the stock market will react CNBCWall St Week Ahead Inflation report could rattle markets after bond yields climb ReutersDecember CPI report expected to show sticky inflation as investors recalibrate rate cut bets Yahoo Finance
|
|